He most recently was President & CEO of EmboMedics, Inc., an early stage medical device company developing resorbable, drug-loadable embolic spheres to treat, among other things, liver cancer. In two years, Mr. Cohen reorganized and recapitalized the Company, redirected product development to advance quickly to FDA submission, and then sold EmboMedics to a larger medical device company. Prior to that, he founded Miromatrix Medical, an early stage biotechnology device company with a patent-protected technology that enables the construction of fully biological human organs for transplant, and grew the enterprise to a $90+ million valuation over seven years by technology development, creating and commercializing two products, extensive partnering and business development activities, regulatory and reimbursement success, and $31 million in fundraising.
Before Miromatrix, Mr. Cohen built significant shareholder value as President & CEO of Travanti Pharma Inc. through technology, product and business development, followed by the successful sale of the company to Teikoku Pharma five years after his arrival. Mr. Cohen has held senior management positions with both large organizations (Pfizer Inc.; Sulzermedica; St. Jude Medical) and small enterprises (Miromatrix Medical; Travanti Pharma; Advanced Circulatory Systems [sold to ZOLL Medical]; Horizon Medical Products [public offering]; GCI Medical), as well as seven Board of Directors positions. Diverse activities have included successfully taking a company public on the NYSE in a billion dollar offering, initiating and developing new products through to market, establishing a manufacturing facility in a foreign tax-friendly environment, a series of acquisitions, divestitures and licensing transactions ranging from several thousand dollars to almost one billion dollars, raising capital for early stage companies, and restructuring sales activities in Japan. Mr. Cohen is able to leverage more than thirty-five years of clinical, distribution, executive, venture capital and investment banking relationships.
Outside of his efforts on behalf of Zomedica, Mr. Cohen’s primary passion is his two boys and their families. Although his playing days are over, he is a big baseball fan, as well as an avid music enthusiast. There were years of playing and coaching baseball in his past, as well as playing in and managing bands and writing original music. His favorite animal is Duke, a beautiful and loving Golden Retriever.